These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32791969)

  • 1. Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?
    Pahus L; Suehs CM; Halimi L; Bourdin A; Chanez P; Jaffuel D; Marciano J; Gamez AS; Vachier I; Molinari N
    BMC Med Ethics; 2020 Aug; 21(1):72. PubMed ID: 32791969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Early achievements of the Danish pharmaceutical industry--8. Lundbeck].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2016; (43):9-61. PubMed ID: 27491172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey on self-medication for the prevention or treatment of COVID-19 and distrust in healthcare of veterans in a primary care setting in the United States.
    Amenta E; Grigoryan L; Dillon L; Hines-Munson C; Van J; Trautner B
    Ther Adv Drug Saf; 2022; 13():20420986221143265. PubMed ID: 36540619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines, editors, pharma and the biological paradigm shift.
    Singh AR; Singh SA
    Mens Sana Monogr; 2007 Jan; 5(1):27-30. PubMed ID: 22058616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Early achievements of the Danish pharmaceutical industry-7].
    Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
    Theriaca; 2014; (42):31-62. PubMed ID: 25816561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting African-American participation in AIDS research.
    Sengupta S; Strauss RP; DeVellis R; Quinn SC; DeVellis B; Ware WB
    J Acquir Immune Defic Syndr; 2000 Jul; 24(3):275-84. PubMed ID: 10969353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race, medical researcher distrust, perceived harm, and willingness to participate in cardiovascular prevention trials.
    Braunstein JB; Sherber NS; Schulman SP; Ding EL; Powe NR
    Medicine (Baltimore); 2008 Jan; 87(1):1-9. PubMed ID: 18204365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions between physicians and the pharmaceutical industry: what does the literature say?
    Lexchin J
    CMAJ; 1993 Nov; 149(10):1401-7. PubMed ID: 8221424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Asset exchange"-interactions between patient groups and pharmaceutical industry: Australian qualitative study.
    Parker L; Fabbri A; Grundy Q; Mintzes B; Bero L
    BMJ; 2019 Dec; 367():l6694. PubMed ID: 31831471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why do people participate in epidemiological research?
    Slegers C; Zion D; Glass D; Kelsall H; Fritschi L; Brown N; Loff B
    J Bioeth Inq; 2015 Jun; 12(2):227-37. PubMed ID: 25672617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceutical industry gifts to physicians: patient beliefs and trust in physicians and the health care system.
    Grande D; Shea JA; Armstrong K
    J Gen Intern Med; 2012 Mar; 27(3):274-9. PubMed ID: 21671130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of pharmaceutical promotion on prescribers in Jordan.
    Altawalbeh SM; Ibrahim IA; Al-Shatnawi SF
    Int J Clin Pharm; 2020 Apr; 42(2):744-755. PubMed ID: 32140917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Criteria for site selection in industry-sponsored clinical trials: a survey among decision-makers in biopharmaceutical companies and clinical research organizations.
    Dombernowsky T; Haedersdal M; Lassen U; Thomsen SF
    Trials; 2019 Dec; 20(1):708. PubMed ID: 31829234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceutical marketing strategies' influence on physicians' prescribing pattern in Lebanon: ethics, gifts, and samples.
    Khazzaka M
    BMC Health Serv Res; 2019 Jan; 19(1):80. PubMed ID: 30700295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Response of Pharmaceutical Companies to the Crisis of Post-Marketing Clinical Trials of Anti-Cancer Agents -- Results of Questionnaires to Pharmaceutical Companies].
    Nakajima T
    Gan To Kagaku Ryoho; 2016 Apr; 43(4):486-9. PubMed ID: 27220801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distrust, race, and research.
    Corbie-Smith G; Thomas SB; St George DM
    Arch Intern Med; 2002 Nov; 162(21):2458-63. PubMed ID: 12437405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of legislative changes in drug promotion on medical students: questionnaire survey.
    Vuorenkoski L; Valta M; Helve O
    Med Educ; 2008 Dec; 42(12):1172-7. PubMed ID: 19120947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trust of Information about Tobacco and E-Cigarettes from Health Professionals versus Tobacco or Electronic Cigarette Companies: Differences by Subgroups and Implications for Tobacco Messaging.
    Vereen RN; Westmaas JL; Bontemps-Jones J; Jackson K; Alcaraz KI
    Health Commun; 2020 Jan; 35(1):89-95. PubMed ID: 30422690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.